Acne
Actinic Keratosis
Aesthetics
Alopecia
Atopic Dermatitis
Buy-and-Bill
COVID-19
Case-Based Roundtable
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Drug Watch
Eczema
General Dermatology
Hidradenitis Suppurativa
Melasma
NP and PA
Pediatric Dermatology
Pigmentary Disorders
Practice Management
Precision Medicine and Biologics
Prurigo Nodularis
Psoriasis
Psoriatic Arthritis
Rare Disease
Rosacea
Skin Cancer
Vitiligo
Wound Care

Navigating Expectations, Strategies, and Challenges in Vitiligo : Episode 11

Opinion

Video

December 12, 2024

Tailoring Treatments and Counseling Patients With Pediatric Vitiligo

Author(s):

Karan Lal, DO, MS, FAAD, discusses how to optimize vitiligo management in pediatric patients through personalized treatment selection and age-appropriate counseling strategies that address both the physical and psychosocial aspects of the condition.

Video Player is loading.

Current Time 0:00

Duration 4:13

Loaded: 0%

Stream Type LIVE

Remaining Time 4:13

EP: 1.Collaborating With Communities to Manage Pediatric Vitiligo

EP: 2.Anticipating Advances for Pediatric Vitiligo

EP: 3.Telehealth and Research Strides for Young Patients

EP: 4.Managing Expectations and Holistically Treating Patients With Vitiligo

EP: 5.Vitiligo Repigmentation Challenges and Evaluating Treatment Success

EP: 6.Clinical Presentation

EP: 7.Promising and Emerging Therapies in the Vitiligo Landscape

EP: 8.The JAK Revolution in Vitiligo

EP: 9.Balancing Safety and Efficacy With Key Data

EP: 10.Vitiligo Treatment Patterns and Pearls for Adults Versus Pediatric Patients

Now Viewing

EP: 11.Tailoring Treatments and Counseling Patients With Pediatric Vitiligo

EP: 12.Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo

EP: 13.Treatment Insights and Evolving Care Options in Vitiligo

EP: 14.Key Differences in Onset, Progression, Diagnosis, and Treatment of Pediatric Vitiligo

EP: 15.Addressing Psychological and Social Impacts of Pediatric Vitiligo

EP: 16.Promoting Open and Positive Dialogue With Families of Patients With Pediatric Vitiligo

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Videos

Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management

Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice

Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments

Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines

The Future of Pediatric Atopic Dermatitis Treatment and Emerging Therapies

What Lies Ahead for GPP Diagnosis and Management

Case 3: High-Risk Patient with GPP Treatment Approach

Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care

Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?

Treatment Escalation and De-escalation Strategies in Pediatric AD: Positioning Ruxolitinib Cream in Clinical Decision-Making